10
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Murine Fetal Liver Augments Proliferation in an Allogenic Mixed Lymphocyte Culture: Benzo(A)Pyrene Reduces Augmentation

Pages 181-200 | Published online: 27 Sep 2008
 

Abstract

The effect of cells from the liver of C3H fetuses syngeneic to splenic responder cells on an allogeneic mixed lymphocyte response (MLR) was studied. After fractionation on ficoll-hypaque, interface cells from corn oil (vehicle for BP) or normal fetal liver (FL) controls (CO), obtained from 17–19 days gestation, enhanced proliferation in the mixed lymphocyte culture (>2-fold), while cells from FLs transplacentally exposed to benzo(a)pyrene (BP) showed a decreased capacity for augmentation (>2-fold less than CO). Unfractionated CO-FL cells at 0.5×106 did not augment proliferation, but at 0.10×256 enhancement with control FL cells was significantly higher than with BP-FL cells. Pelleted cells from BP- and CO-FLs were severely suppressive at the higher dose, while at 0.25×106 proliferation was augmented with CO-FL cells, but not affected with BP-FL cells. At doses of 0.1×106 or less, no effect was observed for either control or BP-FL cells. These data indicate that: a) FL cells syngeneic to responder cells of an allogenic mixed lymphocyte culture (MLC) have an augmenting but not suppressive capacity on cell proliferation; b) in utero insult with BP modifies the capacity of FL cells to augment proliferation in the MLC.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.